The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care.
about
Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapyExploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survivalInterleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer centerOpioid treatment of experimental pain activates nuclear factor-κB.MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.Biomarkers: symptoms, survivorship, and quality of lifeInformative gene network for chemotherapy-induced peripheral neuropathyAssociations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgeryPharmacogenetics of analgesic drugsGenetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patientsPharmacogenetics of chronic pain and its treatment.Effect of interleukin 6 -174G>C gene polymorphism on opioid requirements after total hip replacement.Role of inflammation gene polymorphisms on pain severity in lung cancer patients.Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genesOpioid genetics: the key to personalized pain control?Opioids Resistance in Chronic Pain Management.Genetic susceptibility to postherniotomy pain. The influence of polymorphisms in the Mu opioid receptor, TNF-α, GRIK3, GCH1, BDNF and CACNA2D2 genes.
P2860
Q33940740-3EF81C80-8D1A-4C6E-941B-0722A0F0F4FEQ35122783-BD4A3E55-A7EA-4007-9A16-A4C6ACEC46AAQ35565908-9243A612-EF39-44C6-B577-167AE4E25FE2Q35762790-10338C0C-AB03-4391-B4ED-65C651C62BFBQ35848345-0E991DD1-0611-4293-88DA-9855B206A304Q35866257-7E133E5F-B676-4AE7-9DDE-8BA0F644C38BQ35922750-6959B8BB-7205-4613-85AC-58D9E86CBB17Q35923511-2BB2B070-7614-4912-B6E7-3F04E9F151ECQ35945680-2618DD5F-1BF7-4047-B446-F231BD1A1B60Q35946872-65BA20A0-5AA3-4F2A-A15D-73B221EF88ADQ36110592-2F65DA49-9043-4AB6-B161-62BED06A80CBQ36625873-0C99542C-156A-4C7C-8553-AAB882BE769AQ36900075-2DE192ED-842E-4B1E-8737-57D95ADBE32CQ37116445-C658BC1F-6933-40FB-B4F5-8464EE8F2822Q37382239-4D25A11C-61F2-4CCA-AB9A-102A9958D74FQ37582383-39DB237E-F860-46CF-8429-3E806F9B2498Q38025200-836B0FA4-9F30-4BA9-92EF-636D33D57E2BQ39305721-019875E4-E643-40BF-BBF8-0CBBE96CD03BQ44348473-C8EB839D-19DA-4DBC-A2A7-289F8874051A
P2860
The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The influence of tumor necrosi ...... nts receiving supportive care.
@ast
The influence of tumor necrosi ...... nts receiving supportive care.
@en
type
label
The influence of tumor necrosi ...... nts receiving supportive care.
@ast
The influence of tumor necrosi ...... nts receiving supportive care.
@en
prefLabel
The influence of tumor necrosi ...... nts receiving supportive care.
@ast
The influence of tumor necrosi ...... nts receiving supportive care.
@en
P2093
P2860
P1476
The influence of tumor necrosi ...... nts receiving supportive care.
@en
P2093
Badi El Osta
Cielito C Reyes-Gibby
Henrique Parsons
Margaret R Spitz
Sanjay Shete
P2860
P304
P356
10.1158/1055-9965.EPI-08-0125
P577
2008-11-01T00:00:00Z